CCR6 and neoplasm: Additionally, PD-1 expression on tumor-infiltrating CAR T cells was significantly lower in the HER2-CXCR5-CCR6-CAR T group than in the other treatment groups, indicative of reduced T cell exhaustion (Fig. 6D).